Company news
Nurix Therapeutics, Inc. news in 2020
Nurix Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Nurix Therapeutics Presents Preclinical Data at 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
December 6, 2020
Nurix Therapeutics to Present at Upcoming Investor Conferences
November 8, 2020
Nurix Therapeutics to Present Preclinical Data at Upcoming 5th Medicinal Chemistry & Protein Degradation Summit and 62nd ASH Annual Meeting and Exposition
November 3, 2020
Nurix Therapeutics Announces Appointment of Robert Tjian as Chairman of Scientific Advisory Board and His Resignation from the Board of Directors
October 25, 2020
Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update
October 13, 2020
Nurix Therapeutics to Present at 3rd Annual Targeted Protein Degradation Summit
October 5, 2020
Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering
July 22, 2020
Decks in 2020
- Technical Presentation (December 2020)
Technical · 10 slides · Dec 7, 2020
- TPD Conference 2020
Conference · 20 slides · Oct 14, 2020